Completed OBSERVATIONAL NCT04079127

Avenir Müller Hip Stem Post Market Surveillance Study

A Multi-centre, Non-comparative, Retrospective Post-market Surveillance Study to Obtain Clinical Outcomes Data on the Zimmer Avenir Müller Hip Stem

Sponsor: Zimmer Biomet

Conditions Dislocated Hip Fracture of Hip Osteoarthritis, Hip Osteonecrosis Post-traumatic; Arthrosis Rheumatoid Arthritis Subluxation Hip

Interventions Patients who met the inclusion/exclusion criteria to receive the Avenir Müller stem.

Updated 10 times since 2019 Last updated: Apr 14, 2021 Started: Jan 9, 2010 Primary completion: Jun 29, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Dislocated Hip and Fracture of Hip and is currently completed. Zimmer Biomet leads this study, which shows 10 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Jun 2021 — Dec 2022 [monthly]

Completed

▶ Show 5 earlier versions

May 2021 — Jun 2021 [monthly]

Completed
Jan 2021 — May 2021 [monthly]

Completed
Oct 2020 — Jan 2021 [monthly]

Completed
Jul 2020 — Oct 2020 [monthly]

Completed
Oct 2019 — Jul 2020 [monthly]

Completed

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zimmer Biomet

Data source: Zimmer Biomet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.